This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Kyoto University, Eisai R&d Management Co., Ltd., Osaka University. Active years: 2016-2026.
Company Filing History:
3 out of 866 
2 out of 530 
2 out of 1,040 
Years Active: 2016-2026
Title: Bumpei Samata: Innovator in Dopaminergic Neuron Research
Introduction
Bumpei Samata is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of neuroscience, particularly in the development of methods for producing dopaminergic neuron progenitor cells. With a total of 3 patents, his work is paving the way for advancements in regenerative medicine.
Latest Patents
Samata's latest patents include a method for inducing dopaminergic neuron progenitor cells. This invention outlines a process that involves the adherent culture of pluripotent stem cells on an extracellular matrix, followed by the collection of specific cell types using binding substances. Additionally, he has developed a method for selecting dopaminergic neuron progenitor cells by detecting various markers associated with these cells.
Career Highlights
Throughout his career, Bumpei Samata has worked with prestigious institutions such as Kyoto University and Eisai R&D Management Co., Ltd. His research has focused on innovative techniques that enhance the understanding and application of stem cell technology in treating neurological disorders.
Collaborations
Samata has collaborated with esteemed colleagues, including Jun Takahashi and Daisuke Doi. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Bumpei Samata's work in the field of dopaminergic neuron research exemplifies the impact of innovative thinking in science. His contributions are vital for future developments in regenerative medicine and neuroscience.